# K073213: Therabond Antimicrobial Barrier Systems

- Pathway: 510(k) (Traditional)
- Applicant: Choice Therapeutics
- Decided: May 28, 2008 after 196 days
- Product code: FRO (Dressing, Wound, Drug)
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 4 generations back to K914579 (1992). 6 ancestors in all.
5 later devices descend from it; 1 cites it directly.
0 of 12 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K981299: Silverlon Contact Wound Dressing, Argentum International, LLC (1998) Summary page 1.
- K023612: Silverlon Contact Wound Dressing, Argentum International, LLC (2003) Summary page 1.

## Most influential descendants
- K150256: Silverlon Burn Contact Dressings (2015), 4 descendants of its own
- K190343: Silverlon Wound Contact, Burn Contact Dressings (2019), 3 descendants of its own
- K221218: Silverlon Wound Contact, Burn Contact Dressings (2022), 1 descendant of its own
- K241225: Silverlon® Wound Contact, Burn Contact Dressing (2024), 0 descendants of its own
- K212521: Field Shield Wound Dressing (2024), 0 descendants of its own

## Indications for use
TheraBond Antimicrobial Barrier Systems are indicated for use in light to moderately exuding partial and full thickness wounds including traumatic wounds, surgical wounds, donor sites, 1st and 2nd degree bums, as well as decubitus ulcers, diabetic ulcers and vascular ulcers. TheraBond may be used over debrided and partial thickness wounds.

Source page: https://510kreport.com/device/K073213
Methodology: https://510kreport.com/methodology